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Alzheimer's disease (AD) is a chronic neuro-degenerative
disorder that usually starts after the age of 65 years and
progresses slowly, worsening recall memory in individuals.
With further advancement of the disease, impairments in
language, disorientation, mood swings with ultimate loss
of body functions and death ensue. The cause, of the
disease is considered to be genetic in 70% of the cases,
while other possible risk factors include chronic stressed
conditions such as depression, anxiety, and even hyper-
tension.1 AD progression is associated with formation of
tau entangles and amyloid plaques in the brain, a main
reason of worsening behavioural and physical deterioration
in Alzheimer patients. Examination of brain tissue is
always required for definite diagnosis. Since it cannot be
done in the live subjects, it will be imperative to find any
gene/protein that can become a potential marker for AD;
and may be detected in brain for the potential diagnosis
and treatment of this disorder.2
One of such genes/proteins is a histone binding protein,
RbAp48 (RBBP4), a major genetic risk factor for Alzheimer's
dementia.3 Its deficiency occurs at the dentate-gyrus of
hippocampus in brain. Its main functions are to facilitate
ATP-dependent chromatin remodelling along with histone
deacetylase activity through interaction with H3-H4
dimers combinedly coined as nucleosome remodelling
deacetylase complex; and to act as co-repressor in trans-
cription silencing, regulating cell proliferation, growth
and post- translational modification of the nucleosome.
Any disturbance in its structure or function may interrupt
neuronal activity disrupting memory encoding ability.4
Cloning is a technique where recombinant DNA can be
integrated into host organism for generation of required
genes and eventually desired proteins for the preferred
results. Three Kb pGEMT is the replicon with augmented
T7 and SP6 RNA polymerase having multiple cloning
sites and other essential features that include recognition
of insertion of gene through BstZl, EcoRl and Notl as
well as manifestation of ampicillin resistant gene as
selective marker for vector growth in ampicillin supple-
mented media.5 PCR product of RbAp48 gene can be
incorporated in pGEMT for cloning purpose and trans-
formed into competent cells to achieve the magnitude of
product. Recombinant clones can be directly evaluated
through blue/white selection of colony, restriction
digestion, and electrophoresis of pGEMT generated PCR
copies of the gene. Restriction digestion is done using
restriction endonuclease to separate our gene of interest
from replicon and then perform Sanger sequencing
for mutational analysis (Figure 1). This will assist in
identification of the alteration in the protein sequence
involved in memory loss in AD.
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Figure 1: Different methods for the analysis of PCR cloned products.
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